BSD Medical Corporation (BSDM)’s Investor and Analyst Conference Call Transcript

Turn to page 10, Microthermic is the leading technology. Our thirty six years in providing technology to this market place has really given them some competitive advantages and I think the BSD team has done a remarkable job of choosing the safest, most efficacious versatile wavelength in marketplace. And that’s 915 mega hertz. I won’t spend too much going through the engineering aspect of this. We recently, had our sales team in for an exercise with RNDC looking at the next couple of years of our product development portfolio and this may sound a little hokey, but we gave them a hundred dollars of monopoly money and we said” if you were running product development for this company where would you spend your money?”

And there isn’t one failed representative when they spent their money at the change wavelength of our products. They believe in the marketplace that the 915 is the best one for us to choose when you look at the overall feature benefits. I believe that we need to differentiate that in the marketplace with the initials we talked about. But this is a wavelength that is very versatile. We’ve got regards to tumor size and versatile as it relates to organ. That another way, we have the ability to go from a two centimeter to a seven centimeter tumor in the lungs, kidney or liver. And our synchronous way of alignment technology allows a doctor to provide a more elegant treatment for that patient.

That doesn’t overly treat them potentially compromising safety. It is very easy to use and the ergonomic funds are very nice. Relative to our competition in many cases that larger devices require heavy shipping much like the Hypothermia business so we’re gonna look for leveraging that on the Microthermic platform. It is less time consuming than older technologies and we feel that time is money, no more so than in the hospital system. What I think escaped me when I looked at diligence is, when I was doing Diligence I wanted to see Dr. De Qui provide a treatment. The patient came in, 45 minutes later we were done with the case and the patient got up after being in mild sedation and said doctor “when are we gonna start” and I appreciate Dr. Qui’s answer in saying that we put a band-aid on him, we’re gonna put a tuna sandwich down you and if it stays down we’re gonna send you home tonight. I have the opportunity to see him talk to the patients family about that I’ve since talked to patients. We have video testimonials. With the ability for us to bring a patient in with a cancerous tumor, ablate the tumor and send him out the same day is really quite remarkable compared to older more dull days.